Statement Of Changes In Equity [Abstract]

Mithra Pharmaceuticals S.A. - Filing #3183196

Concept	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity	336 634 EUR	2 545 EUR	340 769 EUR	—	33 840 EUR	—	32 250 EUR	—	—	—	—	219 759 EUR	332 535 EUR	31 271 EUR	—	13 690 EUR	—	—	—	157 737 EUR	3 423 EUR	258 898 EUR	163 298 EUR	127 673 EUR	28 649 EUR
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)	—	—	—	—	—	—	—	—	116 875 EUR	116 875 EUR	92 086 EUR	—	—	—	92 086 EUR	—	—	—	—	—	—	—	—	—	—
Other comprehensive income	—	—	—	—	—	—	—	—	17 300 EUR	—	3 000 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Comprehensive income	—	—	—	17 300 EUR	—	- EUR	—	- EUR	134 175 EUR	116 875 EUR	89 086 EUR	—	—	—	92 086 EUR	—	3 000 EUR	- EUR	- EUR	—	—	—	—	—	—
Issue of equity	—	—	—	—	—	749,000 EUR	—	2 752 EUR	3 501 EUR	—	63,318,000 EUR	—	—	—	—	—	—	60,813,000 EUR	2 505 EUR	—	—	—	—	—	—
Increase (decrease) through share-based payment transactions, equity	—	—	—	1 065 EUR	—	—	—	—	1 065 EUR	—	7 267 EUR	—	—	—	—	—	7 267 EUR	—	—	—	—	—	—	—	—